Hikma Pharmaceutical | HIK - Należności Handlowe





Należności Handlowe Zmiana Data
Almirall EUR 196.15M 20.22M 2026-06
argenx SE USD 2.01B 352.94M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Autolus Therapeutics Ltd USD 38.07M 37.71M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Fresenius EUR 3.78B 299M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 8.07B 137M 2026-06
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.81B 373M 2026-03
Orion EUR 543.8M 155.8M 2026-06
Recordati EUR 764.73M 88.12M 2026-03
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12